A report out today finds members of the trade group PhRMA invested $49.5 billion in research and development last year. John Castellani, PhRMA President & CEO, weighs in.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT